DSTN

Destrin · P60981 · DSTN on Sugi Atlas →

0 patent compounds predicted against DSTN, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to DSTN by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Comparative Study of Strategies for Management of Duchenne Myopathy (DM) PHASE4UNKNOWN
Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast Cancer PHASE3COMPLETED
Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan Syndrome PHASE3COMPLETED
Efficacy and Safety of Oral Immunotherapy With GcMAF in Hospitalized Patients With COVID-19 Pneumonia PHASE2COMPLETED
Evaluation of Nicotinamide Riboside in Prevention of Small Fiber Axon Degeneration and Promotion of Nerve Regeneration PHASE2COMPLETED
Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome PHASE1COMPLETED
FAK Inhibitor in Patients With Advanced Solid Tumors PHASE1NOT_YET_RECRUITING
Evaluation of the Safety and Efficacy of BBM-D101 to Treat Patients with Duchenne Muscular Dystrophy EARLY_PHASE1RECRUITING
Molecular Analysis of Patients With Neuromuscular Disease nanRECRUITING
Genetic Identification (ID) of Segmental Dysplastic Nevi nanWITHDRAWN
The Roles of Neutrophil Elastase in Lung Cancer nanUNKNOWN
Study of the Pathophysiological Mechanisms Involved in Bleeding Events nanCOMPLETED
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
Molecular Mechanisms of the Development of Precancerous and Cancerous Lesions of the Oral Cavity nanCOMPLETED
Clinical Outcome Study for Dysferlinopathy nanUNKNOWN
Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma nanRECRUITING
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease nanRECRUITING
Whole Exome and Whole Genome Sequencing for Genotyping of Inherited and Congenital Eye Conditions nanRECRUITING
Shwachman Diamond Syndrome Registry and Study nanRECRUITING
Evaluation of Desmoglein-3 Autoantibodies in the Tissues of Oral Lichen Planus and Correlation with Disease Severity nanNOT_YET_RECRUITING
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients nanRECRUITING
Study of the Disease Process of Lymphangioleiomyomatosis nanRECRUITING
Clinical and Genetic Analysis in Congenital Hypothyroidism Due to Thyroid Dysgenesis. nanCOMPLETED
Family Myopia Study nanCOMPLETED
Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN) nanRECRUITING
Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms nanCOMPLETED
Circulating Markers for Ischemic Heart Disease nanRECRUITING
Cyclosporin A Therapy in Childhood Nephrotic Syndrome nanUNKNOWN
Identification of Biomarkers for Early Detection of Pancreatic Cancer nanCOMPLETED
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a DSTN binder may also engage these)

ProteinNameSimilarity
P60982 1.000 P60982 →
Q5E9D5 1.000 Q5E9D5 →
P18359 1.000 P18359 →
Q9R0P5 1.000 Q9R0P5 →
Q7M0E3 1.000 Q7M0E3 →
P45695 0.999 P45695 →
P45593 0.996 P45593 →
Q6NX11 0.995 Q6NX11 →
P45594 0.986 P45594 →
Q9VFM9 0.981 Q9VFM9 →
Q17A58 0.981 Q17A58 →
Q6C0Y0 0.979 Q6C0Y0 →
Q7QG28 0.978 Q7QG28 →
Q759P0 0.977 Q759P0 →
Q5RJR2 0.977 Q5RJR2 →
Q6GMH3 0.976 Q6GMH3 →
Q6FV81 0.976 Q6FV81 →
Q5I082 0.976 Q5I082 →
Q6CQ22 0.976 Q6CQ22 →
Q5ZM35 0.975 Q5ZM35 →
Q91YR1 0.975 Q91YR1 →
TWF2 Twinfilin-2 0.975 landscape →
Q640W2 0.975 Q640W2 →
Q7ZXP0 0.974 Q7ZXP0 →
Q298X4 0.974 Q298X4 →
Q9HF97 0.974 Q9HF97 →
P0CM07 0.972 P0CM07 →
Q9Z0P5 0.972 Q9Z0P5 →
P0CM06 0.972 P0CM06 →
Q12792 0.972 Q12792 →